The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) will sponsor the fourth International Cancer Immunotherapy Conference at the New York Marriott Marquis in New York City, Sept. 30-Oct. 3, 2018.
The program will focus on "Translating Science into Survival" and feature talks from more than 60 leaders in the field. The conference will cover all areas of inquiry in cancer immunology and immunotherapy, including: regulating T cells; the tumor microenvironment; genetically engineered T cells; the effects of targeted and immune therapies on immune balance; novel vaccine platforms and combinations; predicting response to immunotherapy; the convergence of technology and cancer immunotherapy; and the microbiome and metabolism.
###
The full program is available here: http://www.cancerimmunotherapyconference.org/program-of-events.
Registration is complimentary for credentialed news media. Contact [email protected] to register.
Cancer center public information officers and communications staff can also register by contacting [email protected].
Those following on social media can join the conversation on Twitter at #cicon18.
Media Contact
Julia Gunther
[email protected]
215-446-6896
@aacr
http://www.cancerimmunotherapyconference.org/
